A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery

NCT00843492 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1351

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis, Venous

Interventions

DRUG: Fondaparinux sodium
DRUG: Nadroparin

Sponsor

GlaxoSmithKline